✨ Free AI Report
Creative Medical Technology Holdings, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Creative Medical Technology Holdings, Inc.
Research Preview

Creative Medical Technology Holdings, Inc.: Business Overview, Financials & Competitive Analysis

Creative Medical Technology Holdings is a commercial-stage biotechnology company focusing on novel biological therapeutics in immunotherapy, endocrinology, urology, neurology, and orthopedics. The company announced re...

Analyst-debate audio for Creative Medical Technology Holdings, Inc.

AskCyborg analysts argue the bull and bear cases for Creative Medical Technology Holdings, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Creative Medical Technology Holdings, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
4/ 10Mixed

Cyborg Score thesis

Early-stage biotech with regulatory validation and large market targets, but minimal market cap and pre-profitability profile...

Read the full analyst-debate transcript →
Industry Regenerative Medicine
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 21, 2026
AI-Verified Research
30+ Page Report

Get the Latest Creative Medical Technology Holdings, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Creative Medical Technology Holdings, Inc. Overview

Pro stress-test →

Creative Medical Technology Holdings is a commercial-stage biotechnology company focusing on novel biological therapeutics in immunotherapy, endocrinology, urology, neurology, and orthopedics. The company announced regulatory approval in January 2026 for its BioDefense Inc. Burn Pit Initiative, enabling a national program to collect expanded molecular and cellular data from veterans affected by burn pit exposure. The company is pursuing AI-enabled regenerative medicine solutions addressing multi-billion-dollar market opportunities.

Strategic Profile

Pro stress-test →

The Burn Pit Initiative is funded using existing partnerships (including Greenstone Biosciences), internal infrastructure, and prior vendor relationships to support AI-driven molecular modeling, iPSC development, and regenerative countermeasure work. CELZ-101 has received FDA Orphan Drug Designation for brittle Type 1 Diabetes, offering potential market exclusivity, with ongoing clinical trials in Type 1 Diabetes and chronic lower back pain representing multi-billion-dollar market opportunities. The company maintains a lean operational footprint with minimal dilution risk from near-term funding needs.

Competitive Landscape

Pro stress-test →

CELZ competes in regenerative medicine and immunotherapy against larger, better-capitalized biotech firms. Direct competitors in stem cell therapeutics include Mesoblast, Fate Therapeutics, and Moderna (cell therapy division). The company's narrow market focus on orphan indications (brittle Type 1 Diabetes) and specialized applications (burn pit exposure recovery) positions it as a niche player with less head-to-head competition but limited addressable markets.

Industry Context

Creative Medical Technology Holdings, Inc. operates in Regenerative Medicine.

Key facts

Founded: Not specified in sources · Headquarters: Phoenix, US · Employees: 4 · Revenue: Not publicly disclosed · Market cap: $7.87M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Creative Medical Technology Holdings, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Creative Medical Technology Holdings, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Stem Cell TherapiesAllogeneic stem cell therapeutics→Cell TherapyEngineered cell therapies for cancer and immune disorders→Cell & Gene TherapymRNA and cell therapy platform→

Compare Creative Medical Technology Holdings, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Creative Medical Technology Holdings, Inc. operates in Regenerative Medicine. See how the rest of the sector scores on the Cyborg framework.

Browse Regenerative Medicine research →
NEW · MCP server

Ask your AI assistant about Creative Medical Technology Holdings, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Creative Medical Technology Holdings, Inc. and its top competitor on Cyborg Score”
“What did Creative Medical Technology Holdings, Inc. do this quarter?”
“Is Creative Medical Technology Holdings, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Creative Medical Technology Holdings, Inc. do?+
Creative Medical Technology Holdings is a commercial-stage biotechnology company focusing on novel biological therapeutics in immunotherapy, endocrinology, urology, neurology, and orthopedics. The company announced re...
What is Creative Medical Technology Holdings, Inc.'s Cyborg Score?+
Creative Medical Technology Holdings, Inc. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Creative Medical Technology Holdings, Inc.'s main competitors?+
Named competitors include Stem Cell Therapies, Cell Therapy, Cell & Gene Therapy. The full competitive landscape is in the AskCyborg report.
How can I get the full Creative Medical Technology Holdings, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Creative Medical Technology Holdings, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Creative Medical Technology Holdings, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Regenerative Medicine research

Companies in the same sector and named competitors, ranked by Cyborg Score.

6Humacyte, Inc.6TELA Bio, Inc.5Organogenesis Holdings Inc.4Longeveron Inc.